BioNotebook: Argos takes another stab at IPO, Third Rock-backed Eleven also files for offering
This article was originally published in Scrip
Executive Summary
After scrapping its plans for an initial public offering in early 2012, Argos Therapeutics is going to try again. Eleven Biotherapeutics, a company backed by Third Rock Ventures, also plans to go public.